Viewing Study NCT02818920


Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2026-03-11 @ 4:30 PM
Study NCT ID: NCT02818920
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-18
First Post: 2016-06-28
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Neoadjuvant Pembrolizumab
Sponsor:
Organization: